The trading will be resumed after October 9, see the following announcement
Xinhua Medical: Announcement of Resolutions of the Eleventh Meeting of the Eighth Session of the Board of Directors
The Eleventh Meeting of the Eighth Session of the Board of Directors of Shandong Xinhua Medical Instrument Co. Adoption of the "Motion on Modification of the Company's Operating Scope";
Because of the company's business development needs, the company's operating scope is now increased to include "Laboratory Animal Equipment, Laboratory Instruments; Production and Sales of Air Purification Products; Equipment Leasing, Financial Leasing", and the modified operating scope will be as follows: "Class II disinfection and sterilization equipment and apparatus (6857), three types of medical high-energy radiation equipment (6832), three types of medical nuclide equipment (6833), two or three types of medical X-ray equipment (6830), two or three types of operating rooms, emergency rooms, diagnostic and treatment room equipment and appliances (6854), two types of stomatology equipment and appliances (6855), two types of medical Ultrasound instruments and related equipment (6823), Class II ward care equipment and appliances (6856), Class II medical laser instrumentation and equipment (6824), Class II and Class III software (6870), Class II stomatology materials (6863) production, sales; license within the scope of the Class II and Class III medical device product sales; license approved within the scope of the disinfectant, disinfectant instrument production, sales. Pharmaceutical equipment, environmental protection equipment sales; instrumentation and supporting software production; housing construction engineering, air purification engineering and interior decoration engineering design, construction, decoration, medical, pharmaceutical equipment installation and building intelligence construction; laboratory animal equipment, laboratory instruments; air purification products production, sales; equipment leasing, financial leasing."
Business scope specific to the approval of the Shandong Provincial Administration for Industry and Commerce shall prevail.
(II) Consideration and adoption of the "Motion on the Amendment of <Articles of Association>"
Due to the expansion of the Company's business, the scope of the Company's operation has changed, according to the Company Law and relevant laws and regulations, the Article 13 of the Articles of Association of the Company shall be amended. The specific modifications are:
"Article 13 is registered in accordance with the law, the company's business scope:
Class II disinfection and sterilization equipment and apparatus (6857), Class III medical high-energy radiography equipment (6832), Class III medical nuclide equipment (6833), Class II and Class III medical X-ray equipment (6830), Class II and Class III operating rooms, Emergency room, diagnostic and treatment room equipment and appliances (6854), Class II stomatology equipment and appliances (6855), Class II medical ultrasound instruments and related equipment (6823), Class II ward care equipment and appliances (6856), Class II medical laser instrumentation and equipment (6824), Class II and Class III software (6870), Class II stomatology materials (6863) production and sales; the scope of the license provisions of Class II and Class III medical devices Sales of Class II and III medical equipment products within the scope of the license; disinfectants, disinfection instruments within the scope of the license approval of the production and sales. Pharmaceutical equipment, environmental protection equipment sales; instrumentation and supporting software production; housing construction engineering, air purification engineering and interior decoration engineering design, construction, decoration, medical, pharmaceutical equipment installation and construction of building intelligence; laboratory animal equipment, laboratory instruments; air purification products production, sales; equipment leasing, financial leasing."
Business scope specific to the approval of the Shandong Provincial Administration for Industry and Commerce shall prevail.
(3) Consideration and adoption of the "Motion on the Second Extension of Resumption of Trading on the Company's Preparation for Non-public Offering of Shares";
In view of the fact that this non-public offering involves the introduction of a strategic investor, which is still subject to the prior review and approval of the Shandong Provincial State-owned Assets Supervision and Administration Commission, and at the same time, feasibility analyses in relation to the fund-raising and investment projects of this non-public offering are still underway. According to the provisions of Shanghai Stock Exchange's Notice on Regulating the Suspension and Resumption of Trading and Related Matters of Listed Companies Preparing for Non-public Offering of Shares (SSE [2014] No. 78), it is agreed that the Company will apply to the Shanghai Stock Exchange for a second extension of resumption of trading, which will be for a period of 20 days, from June 12, 2015 to July 1, 2015, for a period of 20 days.
(4) Consideration and adoption of the "Motion on the Third Extension of Resumption of Trading in the Company's Preparation for Non-public Offering";
The Board of Directors of the Company, after prudent assessment, is of the view that: the Company will not be able to disclose the proposal of this non-public offering before the expiry of the second extension of resumption of trading, and in accordance with the "Notice on Regulating Suspension and Resumption of Trading in Listed Companies and Related Matters in the Preparation for Non-public Offerings of Shares" of the Shanghai Stock Exchange ( SSE [2014] No. 78), it was agreed that the Company would apply to the Shanghai Stock Exchange for the third extension of resumption of trading, and the Company's shares would continue to be suspended from July 2, 2015 to October 9, 2015, and would be submitted to the First Extraordinary Shareholders' General Meeting of 2015 for deliberation; if the Company completes all the demonstration and preparation work of the proposal of this non-public offering before the First Extraordinary Shareholders' General Meeting of 2015, the Company will apply for an earlier resumption of trading. If the Company completes all the arguments and preparations for the non-public offering program before the first extraordinary shareholders' meeting of 2015, the Company will apply for early resumption of trading and disclosure of the non-public offering program, and will cancel the submission of this proposal to the shareholders' meeting for consideration. If the Company completes all the justifications and preparatory work for the non-public offering proposal before October 9, 2015, the Company will apply for early resumption of trading and disclosure of the non-public offering proposal.
(E) Consideration and adoption of the "Proposal on convening the first extraordinary general meeting of 2015 of the Company".